Effect of CYP3A4 Regulors on the PK/PD of Cabozantinib Based on the PBPK-TO Model

JIANG Xiao-quan, WANG Guo-peng, LIU Jing-tong, PAN Fu-lu, SEN Mu-li, YANG Wen-ning,LIU Yang, WANG Zhong-jian

Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (16) : 1358-1366.

PDF(1889 KB)
PDF(1889 KB)
Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (16) : 1358-1366. DOI: 10.11669/cpj.2022.16.007

Effect of CYP3A4 Regulors on the PK/PD of Cabozantinib Based on the PBPK-TO Model

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 57(16): 1358-1366 https://doi.org/10.11669/cpj.2022.16.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1889 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉